Virtual Clinical Trials Market In Global
Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new ... Read More
Artificial intelligence in healthcare is the use of complex algorithms and software in another words artificial intelligence (AI) to emulate human cognition in the analysis, interpretation, and comprehension of complicated medical and healthcare data. Specifically, AI is the ability of computer algorithms to approximate conclusions without direct human input.
What distinguishes AI technology from traditional technologies in health care is the ability to gain information, process it and give a well-defined output to the end-user. AI does this through machine learning algorithms and deep learning. These algorithms can recognize patterns in behavior and create their own logic. In order to reduce the margin of error, AI algorithms need to be tested repeatedly.
The use of AI is predicted to decrease medical costs as there will be more accuracy in diagnosis and better predictions in the treatment plan as well as more prevention of disease.
This report contains market size and forecasts of Artificial Intelligence in Medical Diagnostics in Global, including the following market information:
Global Artificial Intelligence in Medical Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Artificial Intelligence in Medical Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Software Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence in Medical Diagnostics include Aidoc, AliveCor, GE Healthcare, Imagen Technologies, Vuno Inc., IDx Technologies Inc., Siemens Healthcare GmbH, Neural Analytics and Riverain Technologies, and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Intelligence in Medical Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence in Medical Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Medical Diagnostics Market Segment Percentages, by Type, 2021 (%)
Software
Hardware
Services
Global Artificial Intelligence in Medical Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence in Medical Diagnostics Market Segment Percentages, by Application, 2021 (%)
Cardiology
Oncology
Pathology
Radiology
Chest and Lung
Neurology
Others
Global Artificial Intelligence in Medical Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Intelligence in Medical Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence in Medical Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Artificial Intelligence in Medical Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aidoc
AliveCor
GE Healthcare
Imagen Technologies
Vuno Inc.
IDx Technologies Inc.
Siemens Healthcare GmbH
Neural Analytics
Riverain Technologies,
Zebra Medical Vision
Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new ... Read More
Doctors have been using medical imaging techniques to diagnose diseases like cancer for many year ... Read More
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences f ... Read More
The use of AI has grown exponentially in recent years, with financial products and tools such as ... Read More